awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26770419-1E7D1563-6B93-4CEC-A6DD-EB8A7AC9F373
Q26770419-1E7D1563-6B93-4CEC-A6DD-EB8A7AC9F373
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26770419-1E7D1563-6B93-4CEC-A6DD-EB8A7AC9F373
The efficacy and tolerability of mirabegron, a β3 adrenoceptor agonist, in patients with symptoms of overactive bladder
P2860
Q26770419-1E7D1563-6B93-4CEC-A6DD-EB8A7AC9F373
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26770419-1E7D1563-6B93-4CEC-A6DD-EB8A7AC9F373
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c6b82fad710765be8d5ac5e74c68f203c3671d5
P2860
Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder.